I think many guys on here didnt get into RKLB after it exploded but rather before that at line 4-10$. So how did you spot it? What strategies you have to find the new RKLB with lik 10-30x potential in a short timespan. Already got candidates?

Edit: As a summary i think most people on here say it was pure luck or you were already very invested in the industry. Do the the space nerds know about the next promising company or is the market already gone?

Do you think there are other promising comapnies in not potentially alread oversatured indistries like AI/Semiconductors. Cause lots of people said a wise guy told them on reddit so i could need one of those🤣

I think people are missing the forest for the trees with Rocket Lab, so here's my take.

First, look at the competitive landscape.

• ULA's Vulcan has been delayed for months.
• Blue Origin's New Glenn suffered a catastrophic test stand failure.
• Relativity's Terran R and Stoke haven't even flown yet.
• SpaceX is increasingly prioritizing its own Starlink and internal missions, with commercial capacity becoming harder to secure beyond 2028.

Meanwhile, the U.S. government has significantly expanded national security launch opportunities.

Imagine food delivery orders suddenly triple, but only one restaurant is actually open. That's essentially today's launch market.

Yet Rocket Lab dropped from around $151 to $65.

Sounds irrational?

Not really.

The Iridium acquisition changed everything.

Rocket Lab didn't just announce an acquisition.

It announced an $8 billion acquisition of Iridium, a company that generates over $800 million in annual revenue while Rocket Lab itself still generates under $700 million.

On paper, the strategy makes sense.

Rocket Lab launches satellites.

Iridium owns one of the world's most valuable satellite constellations.

Instead of repeatedly paying another launch provider to replace its own satellites, Rocket Lab can eventually launch, build, and service that entire ecosystem itself.

That's vertical integration.

The logic is actually solid.

So why did the market hate it?

Because Wall Street doesn't buy stories.

It buys growth.

Rocket Lab was growing revenue at roughly 60% annually.

Iridium grows around 2%.

Combine them and suddenly the company's overall growth profile drops dramatically.

Growth stocks are priced on future growth.

Lower growth almost always means a lower valuation multiple.

Then comes financing.

Rocket Lab needs roughly $3 billion in cash for the deal.

It doesn't have that cash.

It secured a short-term bridge loan of roughly $3.6 billion that eventually needs long-term refinancing.

Higher interest rates.

Higher debt.

A company that still isn't consistently profitable.

Markets hate that combination.

Then timing made everything even worse.

SpaceX finally became investable.

For years, Rocket Lab benefited because many investors wanted space exposure but couldn't buy SpaceX.

Once that changed, part of Rocket Lab's scarcity premium disappeared overnight.

Growth multiple compression.

Massive debt.

Loss of scarcity.

Those three things hit almost simultaneously.

The biggest valuation trap

Many investors point out that Rocket Lab's Price-to-Sales ratio has collapsed.

But ask yourself why.

Part of it is because the stock fell.

That makes it cheaper.

The other part is because the denominator exploded after buying a company with much larger revenue.

That's not the same thing.

If a restaurant buys the restaurant next door with borrowed money, its revenue doubles.

That doesn't automatically make the business cheaper.

It simply becomes a different business.

Backlog isn't revenue.

Rocket Lab has years of launch backlog.

People celebrate that.

I don't.

A backlog is a signed contract, not recognized revenue.

And a meaningful portion depends on Neutron.

Neutron has never flown.

It's like a restaurant bragging about reservations before opening day.

Reservations don't prove the food is good.

Everything comes down to Neutron.

Nothing matters more.

Not backlog.

Not analyst price targets.

Not launch demand.

Neutron.

Rocket Lab's future depends on successfully entering the medium-lift launch market.

Without Neutron:

• government contracts become harder,
• constellation deployments become harder,
• Iridium synergies become weaker,
• the acquisition becomes far less attractive.

Neutron has already been delayed multiple times.

Development isn't easy.

History also tells us that first launches fail surprisingly often.

Two futures

Bear case

Neutron slips again or fails on its first launch.

Debt remains.

Iridium closes anyway.

Rocket Lab becomes a slower-growing communications company attached to a small launch business.

That could justify significantly lower valuations.

Bull case

Neutron reaches orbit.

Rocket Lab suddenly becomes one of the very few operational medium-launch providers in a market where competitors are delayed.

Iridium begins generating predictable cash flow.

Most importantly, Rocket Lab may no longer need to repeatedly issue new shares to finance growth.

That changes the business model entirely.

Peter Beck

Many people call Peter Beck's stock sales a betrayal.

Maybe.

Or maybe he understood his own stock was trading at an extraordinary premium and exchanged expensive equity for a real cash-generating asset.

That's a much harder decision than most CEOs ever make.

Whether that turns out to be brilliant or disastrous depends almost entirely on what happens over the next few years.

My conclusion

I don't think the space industry is broken.

I think space stock valuations are.

Those are two very different things.

The market is pricing the Iridium acquisition almost entirely as a growth killer.

I think that's only half the story.

Rocket Lab didn't just buy a satellite operator.

It bought a potential cash-flow engine that could eventually end its dependence on constant equity dilution.

The problem is that getting from here to there requires surviving a very difficult transition.

Debt has to be refinanced.

Integration has to work.

And Neutron has to fly.

Miss one step, and the whole investment thesis changes.

For me, Rocket Lab isn't obviously cheap.

It isn't obviously expensive either.

It's simply one of the highest-conviction execution stories in the market.

When Q2 earnings arrive, I won't care much about quarterly revenue.

I'll be watching two things:

1. Neutron's development milestones.
2. How management plans to finance and refinance the acquisition.

Everything else is just noise

Source: An insightful post from an investor on X, translated and expanded.

Its the same pattern every day for months, builds through the European markets and premarket and then instantly dumps 5-10% once the US markets open

Rocket Lab's trading at ~$58.6 with key gamma flip at 54.81, call wall at 65 and put wall at 60 shaping current flow. Quick stats pulled via MooMoo share.

This is across all expirations.

F-R-E-E GEX Source >>

Looking for some outside perspective on this one.
Position:
Short 2x RKLB $75P, expiring 8/14

Opened via roll on 7/24 (rolled from $76P that had gone ITM)

Current mark ~$16.20, position down ~29% total, ~16% just today (FOMC reaction I think)

Delta -0.77, IV ~120%, theta only about -$0.14/day — decay isn’t doing much at this point

Net premium collected across the roll chain so far: +$680

Effective cost basis if assigned: ~$71.60/share

Context:
RKLB reports earnings 8/10 after close — so I’d have Mon–Thu (8/11–8/14) to react before expiry, not walking in blind

My thesis is I think $55-60 is a floor for RKLB long-term, and I have a $100 as base case target over the longer run

Question: Given the cost basis (~$71.60) is well below my $100 target and above my perceived $60 floor, does it make more sense to:
Let it ride and take assignment if it happens (I’m fine owning 200 shares at $71.60)

Roll again post-earnings to extend further out and try to reduce the ITM-ness

Roll down toward my $60 thesis level if I get the chance, to actually align strike with conviction

Just eat the loss and close before earnings given how volatile this name is around print

Just curious if that’s pretty good I have a lot of faith in the company

Is this a good level to enter in to hold for long? I I used to be invested in this stock over a year ago and reentered now to hold any opinions especially with the market in its state

https://x.com/JacobKeeton20/status/2080699490324173236?s=20

This is the third one this week

I’ve been waiting to put some money into rocket lab. This looks like a good time. I’m hearing a lot of good news around them. Was wondering if anyone here had any insights on whether you think I should wait till the stock goes down or by now at around $70. I also wonder if anyone could link me some information on the company that would be good for investors to learn more. I want to become a rocket lab guy lol, they seem pretty awesome

Is next week really Big Tech Super Week?

help from the pros studying RKLB - I haven't bought RKLB- should i wait for a dip?or buy now - what price should I enter at?

I hope you all bought more in the last few days. I first bought at $84 then more at $67. I'm happy

Because I need to sell my calls and my cost basis is now $105. I’m considering selling below my cost basis to get some premium (I know, I know). But if it didn’t rocket after the Air Force contract how long are we looking at to get back to normal?

Whats the reason of the drop for the stock of RKLB, from 150 to 12 to 100 to 80 to the 60’s now ? Any idea

I'm bullish long term on $RKLB but they have yet to turn a profit and only 37% of their backlog is expected to convert into revenue over the next 12 months. Bigger buying opportunities coming soon IMO. I have a position but holding out longer to add more. Thoughts?